Тёмный

How to choose your cell separation technology with confidence [WEBINAR] 

Miltenyi Biotec
Подписаться 8 тыс.
Просмотров 466
50% 1

For more information, visit: www.miltenyibiotec.com/produc... When you choose MACS Technology, you are selecting the right tools for the outcomes you desire in the lab. The core of our MACS Technology, the column, allows you to optimize your cell separations so that you have the perfect cell populations for your downstream assays. We will take you on a deep dive into MACS Technology to show you how to find the right tool for your experiments and introduce our newest fully automated instrument for cell separation that can bring even more flexibility to your lab.
Miltenyi Biotec is a global provider of products and services that empower biomedical discovery and advance cellular therapy. Our innovative tools support research at every level, from basic research to translational research to clinical application. This integrated portfolio enables scientists and clinicians to obtain, analyze, and utilize the cell. Our technologies offer solutions for cellular research, cell therapy, and cell manufacturing. Our more than 30 years of expertise spans research areas including immunology, stem cell biology, neuroscience, cancer, hematology, and graft engineering. In our commitment to the scientific community, we also offer comprehensive scientific support, consultation, and expert training. Today, Miltenyi Biotec has more than 4,700 employees in 23 countries - all dedicated to helping researchers and clinicians around the world make a greater impact on science and health.

Наука

Опубликовано:

 

4 дек 2023

Поделиться:

Ссылка:

Скачать:

Готовим ссылку...

Добавить в:

Мой плейлист
Посмотреть позже
Комментарии    
Далее
Иран и Израиль. Вот и всё
19:43
Просмотров 1,2 млн
Cell Culture Contamination and Quality Control
10:26
Просмотров 15 тыс.
Think Fast, Talk Smart: Communication Techniques
58:20
iPhone socket cleaning #Fixit
0:30
Просмотров 18 млн
How to Soldering wire in Factory ?
0:10
Просмотров 12 млн